Contract sales provider PDI has announced it has bagged a $23m (€17m) deal with an undisclosed pharmaceutical firm. The US based company said the new contract was a year-long agreement with a "top-five pharma company" which targets primary care physicians and specialty audiences. "We believe that our proven expertise in deploying and managing primary care and specialty sales forces was a particularly important factor in selecting PDI," said Michael Marquard, PDI's CEO. This comes as good news for PDI who has being struggling in the past few months as two of its major clients, including GSK, did not renew their contract sales deals with the firm - representing a whopping $100m in lost business. Although PDI will need to pen several other contracts to make up for these recent financial blows. Meanwhile, InVentiv Health recently announced it will buy pharma software provider Innovative Health Strategies for $75m in cash and stock. Under the terms of the acquisition, US-based InVentiv will gain Innovative Health's AWAC.MD business which supports pharma firms with their data analysis. AWAC provides services based on its proprietary IT-driven cost containment and medical consulting solution, including data integration and analysis capabilities such as real-time claims evaluation and disease management. In addition to the initial $75m, Innovative could get additional payments if it exceeds certain financial targets, the companies said. "We have been assessing broader healthcare opportunities for some time as a number of our current offerings have applicability beyond our traditional pharmaceutical customers, and believe there is a significant market opportunity in better managing medical costs and outcomes," said Eran Broshy, Chief Executive Officer of inVentiv Health. "The AWAC team has built a unique IT-driven platform combined with targeted physician-led interventions which has been remarkably effective in tackling these issues." InVentiv also announced it would acquire health care public relations company Chandler Chicco Agency for $65m. The company said it expected both deals to close in the third quarter and to immediately add to its earnings. In other services news, Movianto has inked a logistics contract with the Czech subsidiary of Pierre Fabre's Dermo-Cosmetic unit. Germany-based Movianto will be responsible for a wide range of logistics jobs, from transport to warehousing and delivery to Czech and Slovak wholesalers, pharmacies and medical representatives. Movianto already provides logistics and cool chain distribution services to Pierre Fabre's UK subsidiary.